NHS Framework Agreement for the Supply of Human Albumin
A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
- Source
- OJEU
- Type
- Framework (Supply)
- Duration
- 1.5 year (est.)
- Value
- £70M
- Sector
- HEALTH
- Published
- 16 Apr 2021
- Delivery
- 01 May 2021 to 31 Oct 2022 (est.)
- Deadline
- n/a
Concepts
Location
ITT Lists purchasing points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors working on behalf of the above.
2 buyers
5 suppliers
- Bio Products Laboratory Elstree
- Octapharma Manchester
- Biotest Longbridge
- Grifols Cambridge
- CSL Behring Haywards Heath
Description
NHA Framework Agreement for the supply of Human Albumin. The framework will commence on 1 May 2021 for a period of 18 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
Total Quantity or Scope
The framework will commence on 1 May for a period of 18 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months.
Award Detail
1 | Bio Products Laboratory (Elstree)
|
2 | Octapharma (Manchester)
|
3 | Biotest (Longbridge)
|
4 | Grifols (Cambridge)
|
5 | CSL Behring (Haywards Heath)
|
Award Criteria
Security of supply | 25.0 |
Usability | 5.0 |
PRICE | 70.0 |
CPV Codes
- 33141540 - Albumin
Indicators
- Award on basis of price and quality.
Reference
- OJEU 190489-2021